ALTHX.PA Stock Chart

Theranexus, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The Company's lead drug candidate includes THN102, which is in phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain.